Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatmentRavi Bhatia, Stephen J. Forman, Melissa Holtz et al.|Blood|2003Cited by 541
Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor StudyRavi Bhatia, Daniel J. Weisdorf, Liton Francisco et al.|Blood|2007Cited by 536
Invasive fungal infections in acute myeloid leukemia treated with venetoclax and hypomethylating agentsIbrahim Aldoss, Vinod Pullarkat, Sanjeet Dadwal et al.|Blood Advances|2019Cited by 84
Outcome of Allogeneic Hematopoietic Cell Transplantation after Venetoclax and Hypomethylating Agent Therapy for Acute Myelogenous LeukemiaKaramjeet Sandhu, Vinod Pullarkat, Sanjeet Dadwal et al.|Biology of Blood and Marrow Transplantation|2020Cited by 43